Anticoagulação na fibrilação atrial

Moreira, Dalmo Antonio Ribeiro; Habib, Ricardo Garbe.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 24(3): 9-20, jul.-set.2014.
Artigo Português | LILACS, SES-SP, SES SP - Instituto Dante Pazzanese de Cardiologia, SES-SP | ID: lil-763793

Documentos relacionados

  1. Aspirin is a safe and effective thromboembolic prophylaxis after total knee arthroplasty: a systematic review and meta-analysis.
  2. Thromboembolism prophylaxis practices of pediatric and congenital electrophysiologists during invasive electrophysiology studies: A PACES survey.
  3. Thromboembolic and hemorrhagic complications in patients with prosthetic heart valves cared for in a tertiary care center. What have we learned?
  4. Society for Maternal-Fetal Medicine Consult Series #61: Anticoagulation in pregnant patients with cardiac disease.
  5. Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial.
  6. Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?
  7. Prevention of venous thromboembolism in right heart-sided electrophysiological procedures: results of an European Heart Rhythm Association survey.
  8. Individualized approaches to thromboprophylaxis in atrial fibrillation.
  9. Risk-adjusted perioperative bridging anticoagulation reduces bleeding complications without increasing thromboembolic events in general and visceral surgery.
  10. [Anticoagulant efficacy of different pharmacological presentations of vitamin K antagonists].